Veterinary Medicines

RABISIN, suspensie injectabilă

Authorised
  • Rabies virus, strain G52, Inactivated
Download as PDF

Identifikacija zdravila

Ime zdravila:
RABISIN, suspensie injectabilă
Učinkovina:
Ciljne živalske vrste:
Pot uporabe:
  • Subkutana uporaba
  • intramuskularna uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    2.09
    log 10 optical density 50
    /
    1.00
    millilitre(s)
Farmacevtska oblika:
  • Suspenzija za injiciranje
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
    • Dog
    • govedo
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Ferret
  • Intramuscular use
    • Dog
    • Cat
    • govedo
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Ferret
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QI07AA02
Pravni status za dobavo / izdajo zdravila:
Ta podatek za to zdravilo ni na voljo.
Status dovoljenja:
  • Valid
Authorised in:
  • Romania
Opis ovojnine:

Dodatne informacije

Entitlement type:
Pravna podlaga za izdajo dovoljenja za promet z zdravilom:
Imetnik dovoljenja za promet z zdravilom:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Boehringer Ingelheim Animal Health France
Pristojni organ:
  • Institute For Control Of Biological Products And Veterinary Medicines
Številka dovoljenja :
  • 150136
Datum spremembe statusa dovoljenja:

Dokumenti

Povzetek glavnih značilnosti zdravila

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
Romanian (PDF)
Objavljeno na: 7/12/2021
Prenesi
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."